|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | High-level expression of the xylanase from Thermomyces lanuginosus in Eseherichia coli显示文摘 | Yin EK Le YL Pei JJ | 2008 | World J Microbiol Biotechnol2008，24，2： | 1 |
| 2 | High-level expressionof the xylanase from Thermomyces lanuginosus inEscherichia coli显示文摘 | Yin EK Le YL Pei JJ | 2008 | World Journal of Microbiologyand Biotechnology2008，24，27： | 1 |
| 3 | siRNAs against the Epstein Barr virus latency replication factor,EBNA1,inhibit its function and growth of EBV-dependent tumor cells显示文摘 | Yin Q Flemington EK | 2006 | Virology2006，346，2： | 1 |
| 4 | The sample average approximation method for empty container repositioning with uncertainties显示文摘 | Yin Long Loo Hay Lee Ek Pcng Chew | 2012 | European Journal of Operational Research2012，222，1： | 1 |
| 5 | siRNAs against the Epstein Barr virus latency replication factor, EBNA1, inhibit its function and growth of EBV-dependent tumor eells显示文摘 | Yin Q Flemington EK | 2006 | Virology2006，346，2： | 1 |
| 6 | Capillary electrophoresis coupling with electrochemi-luminescence detection:a review显示文摘 | Yin XB Wang EK | 2005 | Anal Chim Acta2005，533，： | 1 |
| 7 | Refrac- tive errors,intraocular pressure, and glaucoma in a white popu- lation 显示文摘 | Yin WT Barbara EK Ronald K Michael K Kristine EL | 2003 | Ophthalmology2003，110，3： | 1 |
| 8 | MicroRNA miR-155 inhibits bone morphogenetic protein (BMP) signaling and BMP-mediated Epstein-Barr virus reactivation 显示文摘 | Yin Q Wang X Flemington EK | 2010 | J Virol2010，84，13： | 1 |
| 9 | High-level expression of the xylanase from Thermomyces lanuginosus in Eseherichia coli显示文摘 | Yin EK Le YL Pei J J | 2008 | World J Microbiol Biotechnol2008，24，2： | 1 |
| 10 | siRNAs against the Epstein Barr virus latency replication factor, EBNA1, inhibit its function and growth of EBV-dependent tumor cells显示文摘 | Yin Q Flemington EK | 2006 | Virology2006，346，2： | 1 |
| 11 | Oncological and functional results following operation for giant cell tumour of bone显示文摘Objective:Giant cell tumours(GCT)represent one of the most common benign tumours of bone.However,despite its benign nature they are aggressive lesions that have a tendency to recur.This study aims to report experience with the treatment of GCTs,and reviews the relationship between surgical management and clinical outcome.Methods:A retrospective review was performed with 70 patients(32 males and 38 females)who presented to our institution between 1991 and 2001 with GCT of bone.An evaluation of the oncological and functional results was conducted and patients were divided into three groups according to the treatment method;GroupⅠ:(46 patients)intralesional curettage and adjuvant therapy and packing with filling materials.GroupⅡ:(18 patients)en-bloc resection and arthrodesis or reconstruction.GroupⅢ:(6 patients)amputation.Results:The mean follow-up period was 10 years(range,5-15 years).The overall rate of local recurrence was 14%,22% in Group I,and only 4% in GroupⅡ and GroupⅢ.According to the Musculoskeletal Tumour Society(MSTS)score for functional outcome,the mean overall score for Group I was 27.9(out of 30),15.9 for GroupⅡ.Of note,the 9 patients within GroupⅡ who received endoprosthetic reconstruction,the mean overall MSTS functional score was 25.5.Conclusion:Intralesional curettage with adjuvant therapies and filling agents is often associated with a relatively high recurrence rate,however joint function is well preserved.Patients with more extensive,biologically aggressive,and/or recurrent tumours are best treated with en-bloc resection. | Yongzhong Wei Eugene T.H. Ek Lipeng Yu Guoyong Yin | 2008 | Journal of Nanjing Medical University2008，22，2： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员